Portfolio company
Quickr
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a biotechnology platform for real-time quantification of genetic modifications for researchers and pharmaceutical developers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QuantaLife
This company develops digital polymerase chain reaction systems for laboratories to identify and quantify DNA molecules for genetic analysis and disease diagnosis.
Cellular Research
This company develops single-cell genetic analysis tools for academic and industrial researchers to quantify gene expression in individual cells.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
QDTI
This company develops quantum sensing instruments for biomarker detection used by researchers, pharmaceutical companies and clinicians for drug discovery and diagnostic testing.
Probius
This company develops bioanalytical platforms using quantum electrochemical spectroscopy to provide biochemical data for pharmaceutical, biotechnology and healthcare researchers.
Geneseque
This company develops a single-molecule DNA sequencing technology for the life sciences sector and research partners.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
